FinAd research workflow
finad.shardingsmeet.com
LoginSign up
Research mode active. Personalized investment actions require suitability and advisor approval.

FinAd is in research and education mode by default. Outputs are probabilistic research signals, not guaranteed returns or personalized investment advice.

Personalized investment recommendations for Indian securities must be reviewed and approved by a SEBI-registered investment adviser or authorized expert workflow before being shown as advice.

NSE:MANKIND

Mankind Pharma

Healthcare / Healthcare. Analysis combines daily candles, derived indicators, fundamentals, news intelligence, and review-gated recommendations.

quality
44
momentum
52
valuation
57
news
50
liquidity
70
risk
54

Recommendations by horizon

NSE:MANKIND / 20D

Mankind Pharma

momentum-trend
WATCHLISTResearch mode
Confidence47/100
Risk54/100
Why this is ranked here
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Leverage is high enough to warrant balance-sheet review.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 619.18 - 635.04 around confirmed liquidity
Invalidation: N/A
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0
NSE:MANKIND / 6M

Mankind Pharma

balanced-ai-blend
WATCHLISTAdvisor approved
Confidence46/100
Risk54/100
Why this is ranked here
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Leverage is high enough to warrant balance-sheet review.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 613.41 - 635.04 around confirmed liquidity
Invalidation: N/A
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0
NSE:MANKIND / MULTI_YEAR

Mankind Pharma

quality-compounder
WATCHLISTResearch mode
Confidence49/100
Risk54/100
Why this is ranked here
  • No promoter pledge is present in the sample fundamental snapshot.
What can go wrong
  • Leverage is high enough to warrant balance-sheet review.
  • All signals are probabilistic and require SEBI-registered advisor review before personalized advice.
Entry: 613.41 - 635.04 around confirmed liquidity
Invalidation: N/A
Freshness: 2026-05-07
Model: finad-explainable-v0.1.0